Lawsuit Overview
An investor in TLCR stock filed a lawsuit in Delaware Court on behalf of current investors Talecris Biotherapeutics Holdings Corp (NASDAQ:TLCR) alleging breaches of fiduciary duty by the board of directors of Talecris Biotherapeutics Holdings Corp for selling the company too cheaply to Grifols. Talecris Biotherapeutics Holdings Corp. is a biopharmaceutical company that produces and m...
You must register (for free) or login to view the entire case.